Schreiber RD - Search Results

1

Schumacher TN, Schreiber RD. Schumacher TN, et al. Among authors: schreiber rd. Science. 2015 Apr 3;348(6230):69-74. doi: 10.1126/science.aaa4971. Science. 2015. PMID: 25838375 Review.

2

Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets.

Bach EA, Szabo SJ, Dighe AS, Ashkenazi A, Aguet M, Murphy KM, Schreiber RD. Bach EA, et al. Among authors: schreiber rd. Science. 1995 Nov 17;270(5239):1215-8. doi: 10.1126/science.270.5239.1215. Science. 1995. PMID: 7502050

3

Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, Shiku H, Schreiber RD, Allen PM. Hanson HL, et al. Among authors: schreiber rd. Immunity. 2000 Aug;13(2):265-76. doi: 10.1016/s1074-7613(00)00026-1. Immunity. 2000. PMID: 10981969 Free article.

4

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD. Yin L, et al. Among authors: schreiber rd. Science. 2001 Mar 16;291(5511):2162-5. doi: 10.1126/science.1058453. Science. 2001. PMID: 11251123

5

Interferon-gamma and cancer immunoediting.

Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Immunol Res. 2005;32(1-3):231-45. doi: 10.1385/ir:32:1-3:231. Immunol Res. 2005. PMID: 16106075 Review.

6

Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.

Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, Schreiber RD, Murphy TL, Murphy KM. Hildner K, et al. Among authors: schreiber rd. Science. 2008 Nov 14;322(5904):1097-100. doi: 10.1126/science.1164206. Science. 2008. PMID: 19008445 Free PMC article.

7

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Schreiber RD, Old LJ, Smyth MJ. Schreiber RD, et al. Science. 2011 Mar 25;331(6024):1565-70. doi: 10.1126/science.1203486. Science. 2011. PMID: 21436444 Review.

8

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.

Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, Smyth MJ, Old LJ, Mardis ER, Schreiber RD. Matsushita H, et al. Among authors: schreiber rd. Nature. 2012 Feb 8;482(7385):400-4. doi: 10.1038/nature10755. Nature. 2012. PMID: 22318521 Free PMC article.

9

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.

Vesely MD, Schreiber RD. Vesely MD, et al. Among authors: schreiber rd. Ann N Y Acad Sci. 2013 May;1284(1):1-5. doi: 10.1111/nyas.12105. Ann N Y Acad Sci. 2013. PMID: 23651186 Free PMC article.

10

New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.

Mittal D, Gubin MM, Schreiber RD, Smyth MJ. Mittal D, et al. Among authors: schreiber rd. Curr Opin Immunol. 2014 Apr;27:16-25. doi: 10.1016/j.coi.2014.01.004. Epub 2014 Feb 14. Curr Opin Immunol. 2014. PMID: 24531241 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page